CAD 0.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 5564.00 | 5364.00 | 2584.00 | - | - | - |
Gross Profit | -5564.00 | -5364.00 | -2584.00 | - | - | - |
Operating Expenses | 964.79 Thousand | 2.33 Million | 806.71 Thousand | 1.53 Million | 295.22 Thousand | 705.06 Thousand |
Selling, General and Administrative Expenses | 964.79 Thousand | 2.33 Million | 806.71 Thousand | 1.53 Million | 295.22 Thousand | 705.06 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | -287.84 Thousand | - | - | 146.88 Thousand |
Cost and Expenses | 964.79 Thousand | 2.33 Million | 809.3 Thousand | 1.53 Million | 295.22 Thousand | 705.06 Thousand |
Operating Income | -964.79 Thousand | -2.33 Million | -3.5 Million | -1.54 Million | -295.22 Thousand | -558.18 Thousand |
Interest Expense | - | - | - | - | - | 3922.00 |
Income Tax Expense | - | -709.00 | -2.69 Million | -220.94 Thousand | -171.86 Thousand | -10.33 Thousand |
Earnings before Tax | -1.21 Million | -2.33 Million | 1.6 Million | -1.51 Million | -265.07 Thousand | -614.62 Thousand |
Net Income | -1.21 Million | -2.33 Million | 1.6 Million | -1.51 Million | -265.07 Thousand | -614.62 Thousand |
Earnings Per Share Basic | -0.01 | -0.02 | 0.02 | -0.02 | -0.00 | -0.01 |
Earnings Per Share Diluted | -0.01 | -0.02 | 0.02 | -0.02 | -0.00 | -0.01 |
Weighted Average Shares Outstanding | 127.21 Million | 119.77 Million | 97.51 Million | 80.53 Million | 71.03 Million | 67.68 Million |
Weighted Average Shares Outstanding (Diluted) | 127.21 Million | 119.77 Million | 97.51 Million | 80.53 Million | 71.03 Million | 67.68 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -964.79 Thousand | -2.33 Million | -528.06 Thousand | -1.54 Million | - | -558.18 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 1406.00 | 1410.00 | 1390.00 | 5564.00 | 5564.00 | - |
Gross Profit | -1406.00 | -1410.00 | -1390.00 | -5564.00 | -5564.00 | - |
Operating Expenses | 113.87 Thousand | 119.79 Thousand | 216.16 Thousand | 1.2 Million | 710.92 Thousand | 364.46 Thousand |
Selling, General and Administrative Expenses | 75.1 Thousand | 119.79 Thousand | 216.16 Thousand | - | 710.92 Thousand | 364.46 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 38.77 Thousand | - | - | - | - | - |
Cost and Expenses | 115.28 Thousand | 121.2 Thousand | 217.55 Thousand | 1.21 Million | 716.48 Thousand | 364.46 Thousand |
Operating Income | -115.28 Thousand | -121.21 Thousand | -217.56 Thousand | -1.21 Million | -716.48 Thousand | -364.47 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | -41.88 Thousand | -4.00 | -4.00 | 39.58 Thousand |
Earnings before Tax | -111.29 Thousand | -123.16 Thousand | -222.41 Thousand | -1.21 Million | -712.14 Thousand | -369.4 Thousand |
Net Income | -111.29 Thousand | -123.16 Thousand | -222.41 Thousand | -1.21 Million | -712.14 Thousand | -369.4 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.01 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.01 | -0.00 |
Weighted Average Shares Outstanding | 136.5 Million | 127.18 Million | 125.42 Million | 127.21 Million | 130.45 Million | 127.37 Million |
Weighted Average Shares Outstanding (Diluted) | 136.5 Million | 127.18 Million | 125.42 Million | 127.21 Million | 130.45 Million | 127.37 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -113.73 Thousand | -119.8 Thousand | -216.17 Thousand | - | -710.92 Thousand | -364.47 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
LADDERUP
1718
TKOI
BIO
BENGALASM
ZRSEF